1. Home
  2. PTIX vs BBLG Comparison

PTIX vs BBLG Comparison

Compare PTIX & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protagenic Therapeutics Inc.

PTIX

Protagenic Therapeutics Inc.

HOLD

Current Price

$1.66

Market Cap

3.2M

Sector

Health Care

ML Signal

HOLD

BBLG

Bone Biologics Corp

HOLD

Current Price

$1.97

Market Cap

2.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTIX
BBLG
Founded
1994
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
2.4M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
PTIX
BBLG
Price
$1.66
$1.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
103.8K
41.9K
Earning Date
11-26-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$1.30
52 Week High
$14.28
$7.74

Technical Indicators

Market Signals
Indicator
PTIX
BBLG
Relative Strength Index (RSI) 33.67 58.54
Support Level $1.46 $1.88
Resistance Level $1.70 $2.16
Average True Range (ATR) 0.18 0.16
MACD -0.00 0.08
Stochastic Oscillator 20.65 83.98

Price Performance

Historical Comparison
PTIX
BBLG

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About BBLG Bone Biologics Corp

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

Share on Social Networks: